Navellier & Associates »

BioCryst Pharmaceuticals shares owned by Navellier & Associates

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Navellier & Associates from 13F filings

Historical chart of Navellier & Associates investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by Navellier & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by Navellier & Associates

Quarter filed Position value Share count Share price at filing
2025-09-30 $508k 67k 7.59
2025-06-30 $205k 23k 8.96